|
JP3917662B2
(ja)
|
1996-02-14 |
2007-05-23 |
日立化成工業株式会社 |
非複屈折性光学用樹脂組成物及びこれを用いた光学用素子
|
|
EA002113B1
(ru)
|
1996-09-04 |
2001-12-24 |
Пфайзер Инк. |
Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
|
|
US6258822B1
(en)
*
|
1997-08-06 |
2001-07-10 |
Abbott Laboratories |
Urokinase inhibitors
|
|
US6133290A
(en)
|
1998-07-31 |
2000-10-17 |
Eli Lilly And Company |
5-HT1F agonists
|
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US20030134836A1
(en)
|
2001-01-12 |
2003-07-17 |
Amgen Inc. |
Substituted arylamine derivatives and methods of use
|
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US20020147198A1
(en)
|
2001-01-12 |
2002-10-10 |
Guoqing Chen |
Substituted arylamine derivatives and methods of use
|
|
US7102009B2
(en)
|
2001-01-12 |
2006-09-05 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US7429609B2
(en)
|
2002-05-31 |
2008-09-30 |
Eisai R & D Management Co., Ltd. |
Pyrazole compound and medicinal composition containing the same
|
|
WO2004078746A2
(en)
|
2003-02-28 |
2004-09-16 |
Bayer Pharmaceuticals Corporation |
2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
|
|
TWI422583B
(zh)
|
2003-03-07 |
2014-01-11 |
參天製藥股份有限公司 |
具有以４-吡啶烷硫基為取代基之新穎化合物
|
|
EP2385041B1
(en)
|
2003-05-01 |
2013-09-18 |
Bristol-Myers Squibb Company |
Pyrazole-amine compounds useful as kinase inhibitors
|
|
EP1628661A2
(en)
|
2003-06-05 |
2006-03-01 |
Vertex Pharmaceuticals Incorporated |
Modulators of vr1 receptor
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
JP2007519753A
(ja)
|
2004-01-30 |
2007-07-19 |
スミスクライン ビーチャム コーポレーション |
化合物
|
|
DE102004028862A1
(de)
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
WO2006032851A1
(en)
|
2004-09-20 |
2006-03-30 |
Biolipox Ab |
Pyrazole compounds useful in the treatment of inflammation
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
WO2006053227A2
(en)
|
2004-11-10 |
2006-05-18 |
Synta Pharmaceuticals Corp. |
Il-12 modulatory compounds
|
|
TW200628463A
(en)
|
2004-11-10 |
2006-08-16 |
Synta Pharmaceuticals Corp |
Heteroaryl compounds
|
|
ATE451363T1
(de)
|
2005-01-26 |
2009-12-15 |
Schering Corp |
3-(indazol-5-yl)-(1,2,4)triazinderivate und verwandte verbindungen als proteinkinaseinhibitoren zur behandlung von krebs
|
|
US20060223849A1
(en)
|
2005-03-14 |
2006-10-05 |
Mjalli Adnan M |
Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
|
|
DE102005014089A1
(de)
|
2005-03-22 |
2006-09-28 |
Schering Ag |
Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
|
US7553964B2
(en)
|
2005-06-03 |
2009-06-30 |
Abbott Laboratories |
Cyclobutyl amine derivatives
|
|
FR2889526B1
(fr)
|
2005-08-04 |
2012-02-17 |
Aventis Pharma Sa |
7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
US8247556B2
(en)
|
2005-10-21 |
2012-08-21 |
Amgen Inc. |
Method for preparing 6-substituted-7-aza-indoles
|
|
WO2007058626A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
|
US7816535B2
(en)
|
2006-01-25 |
2010-10-19 |
Synta Pharmaceuticals Corp. |
Vinyl-phenyl derivatives for inflammation and immune-related uses
|
|
CN101379060B
(zh)
|
2006-02-10 |
2012-05-23 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
US8658801B2
(en)
|
2006-02-16 |
2014-02-25 |
Syngenta Crop Protection, Llc |
Pesticides containing a bicyclic bisamide structure
|
|
AU2007227210A1
(en)
|
2006-03-20 |
2007-09-27 |
Synta Pharmaceuticals Corp. |
Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
|
|
AU2007230911A1
(en)
|
2006-03-23 |
2007-10-04 |
Synta Pharmaceuticals Corp. |
Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
AR063311A1
(es)
|
2006-10-18 |
2009-01-21 |
Novartis Ag |
Compuestos organicos
|
|
US7960567B2
(en)
|
2007-05-02 |
2011-06-14 |
Amgen Inc. |
Compounds and methods useful for treating asthma and allergic inflammation
|
|
GB0716414D0
(en)
|
2007-08-22 |
2007-10-03 |
Syngenta Participations Ag |
Novel insecticides
|
|
WO2009035951A2
(en)
|
2007-09-11 |
2009-03-19 |
Arete Therapeutics, Inc. |
Soluble epoxide hydrolase inhibitors
|
|
US8324219B2
(en)
|
2007-09-20 |
2012-12-04 |
Synta Pharmaceuticals Corp. |
Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
|
|
WO2009038784A1
(en)
|
2007-09-21 |
2009-03-26 |
Amgen Inc. |
Triazole fused heteroaryl compounds as p38 kinase inhibitors
|
|
DE102007047735A1
(de)
|
2007-10-05 |
2009-04-09 |
Merck Patent Gmbh |
Thiazolderivate
|
|
WO2009061730A2
(en)
|
2007-11-05 |
2009-05-14 |
Array Biopharma Inc. |
4-heteroaryl-substituted phenoxyphenylacetic acid
|
|
EP2215094B1
(en)
|
2007-11-15 |
2016-01-27 |
YM BioSciences Australia Pty Ltd |
N-containing heterocyclic compounds
|
|
WO2009073788A1
(en)
|
2007-12-07 |
2009-06-11 |
Firestone Leigh H |
Compositions and methods for treating menopausal females
|
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
|
CA2722704A1
(en)
|
2008-04-28 |
2009-11-05 |
Zalicus Pharmaceuticals Ltd. |
Cyclylamine derivatives as calcium channel blockers
|
|
NZ603525A
(en)
|
2008-06-27 |
2015-02-27 |
Celgene Avilomics Res Inc |
Pyrimidine based compound and uses thereof
|
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
MX2011010218A
(es)
|
2009-04-02 |
2011-10-10 |
Merck Patent Gmbh |
Inhibidores de autotaxina.
|
|
RU2012116124A
(ru)
|
2009-09-21 |
2013-10-27 |
Вандербилт Юниверсити |
О-БЕНЗИЛ НИКОТИНАМИДНЫЕ АНАЛОГИ КАК ПОЗИТИВНЫЕ АЛЛОСТЕРИЧЕСКИЕ МОДУЛЯТОРЫ mGluR5
|
|
US20120202814A1
(en)
|
2009-10-02 |
2012-08-09 |
Università Degli Studi Di Siena |
Compounds with ddx3 inhibitory activity and uses thereof
|
|
WO2011123937A1
(en)
|
2010-04-06 |
2011-10-13 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
US8822447B2
(en)
|
2010-04-22 |
2014-09-02 |
Janssen Pharmaceutica Nv |
Indazole compounds useful as ketohexokinase inhibitors
|
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
JP6112486B2
(ja)
|
2010-04-27 |
2017-04-12 |
カルシメディカ，インク． |
細胞内カルシウムを調節する化合物
|
|
US20130053382A1
(en)
|
2010-04-30 |
2013-02-28 |
Sunil Paliwal |
Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1)
|
|
EP2609089A1
(en)
|
2010-08-27 |
2013-07-03 |
Universität des Saarlandes |
Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
PL2616444T3
(pl)
|
2010-09-14 |
2016-04-29 |
Inst Biochemii I Biofizyki Pan |
Związki będące modulatorami zmutowanego białka CFTR oraz ich zastosowanie w leczeniu chorób związanych z zaburzeniami w funkcjonowaniu białka CFTR
|
|
NO2638031T3
(https=)
*
|
2010-11-10 |
2018-03-10 |
|
|
|
US8791112B2
(en)
|
2011-03-30 |
2014-07-29 |
Arrien Pharmaceuticals Llc |
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
|
|
BR112013025142A2
(pt)
|
2011-04-01 |
2019-09-24 |
Univ Utah Res Found |
análogos de 3-(1h-benzo{d}imidazol-2-il)-1h-indazol substituído como inibidores da cinase pdk1
|
|
RU2637936C2
(ru)
|
2011-05-23 |
2017-12-08 |
Элан Фармасьютикалз, Инк. |
Ингибиторы активности киназы lrrk2
|
|
KR20140095513A
(ko)
|
2011-11-01 |
2014-08-01 |
에프. 호프만-라 로슈 아게 |
이미다조피리다진 화합물
|
|
HK1203412A1
(en)
|
2011-12-28 |
2015-10-30 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
WO2013106432A1
(en)
|
2012-01-09 |
2013-07-18 |
X-Rx, Inc. |
Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof
|
|
KR20160046693A
(ko)
|
2012-04-02 |
2016-04-29 |
싸이토키네틱스, 인코포레이티드 |
횡격막 기능을 향상시키는 방법들
|
|
US8962322B2
(en)
|
2012-12-03 |
2015-02-24 |
City Of Hope |
Enhancers of induced pluripotent stem cell reprogramming
|
|
PE20191245A1
(es)
|
2013-01-15 |
2019-09-18 |
Incyte Holdings Corp |
Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim
|
|
WO2014134774A1
(en)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
WO2014150981A1
(en)
|
2013-03-15 |
2014-09-25 |
Elan Pharmaceuticals, Llc |
Inhibitors of lrrk2 kinase activity
|
|
US10005720B2
(en)
|
2013-04-05 |
2018-06-26 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
|
CN105228983A
(zh)
|
2013-05-30 |
2016-01-06 |
普莱希科公司 |
用于激酶调节的化合物及其适应症
|
|
EP3004098B1
(en)
|
2013-06-06 |
2017-08-09 |
Chiesi Farmaceutici S.p.A. |
Kinase inhibitors
|
|
KR20160023676A
(ko)
|
2013-06-21 |
2016-03-03 |
에프. 호프만-라 로슈 아게 |
RORc 조절제로서 아릴 설탐 유도체
|
|
CA2919783C
(en)
|
2013-08-02 |
2018-02-06 |
Pfizer Inc. |
Heterobicycloaryl rorc2 inhibitors and methods of use thereof
|
|
US9718818B2
(en)
|
2013-08-22 |
2017-08-01 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
EP3082805B1
(en)
|
2013-12-20 |
2020-02-05 |
Institute for Drug Discovery, LLC |
Substituted amino triazoles, and methods using same
|
|
EP3190889B1
(en)
|
2014-09-03 |
2021-11-17 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
US20160113931A1
(en)
|
2014-10-24 |
2016-04-28 |
University Of Macau |
Method of treating and/or preventing neurodegenerative diseases
|
|
CA2968299A1
(en)
|
2014-11-18 |
2016-05-26 |
Rutgers, The State University Of New Jersey |
Novel mitochondrial uncouplers for treatment of metabolic diseases and cancer
|
|
JO3705B1
(ar)
|
2014-11-26 |
2021-01-31 |
Bayer Pharma AG |
إندازولات مستبدلة جديدة، عمليات لتحضيرها، مستحضرات دوائية تحتوي عليها واستخدامها في إنتاج أدوية
|
|
EP3270694A4
(en)
|
2015-02-17 |
2018-09-05 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP3265445B1
(en)
|
2015-03-06 |
2021-05-05 |
Pharmakea, Inc. |
Lysyl oxidase-like 2 inhibitors and uses thereof
|
|
KR20180030201A
(ko)
*
|
2015-07-23 |
2018-03-21 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
화합물
|
|
CA2995094A1
(en)
|
2015-08-07 |
2017-02-16 |
Calcimedica, Inc. |
Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
|
|
EP3350158A4
(en)
|
2015-09-16 |
2019-05-08 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
WO2017049409A1
(en)
|
2015-09-25 |
2017-03-30 |
The Centre For Drug Research And Development |
Compositions for promoting readthrough of premature termination codons, and methods of using the same
|
|
JP2019513700A
(ja)
|
2016-03-16 |
2019-05-30 |
バイエル・クロップサイエンス・アクチェンゲゼルシャフト |
殺有害生物剤及び植物保護剤としてのｎ−（シアノベンジル）−６−（シクロプロピル−カルボニルアミノ）−４−（フェニル）−ピリジン−２−カルボキサミド誘導体及び関連する化合物
|
|
CN108884068B
(zh)
|
2016-03-24 |
2021-02-26 |
特殊治疗有限公司 |
作为dub抑制剂的1-氰基-吡咯烷衍生物
|
|
WO2017201585A1
(en)
*
|
2016-05-26 |
2017-11-30 |
Genea Ip Holdings Pty Ltd |
Modulators of dux4 for regulation of muscle function
|
|
TWI800498B
(zh)
|
2016-12-21 |
2023-05-01 |
義大利商吉斯藥品公司 |
作為Rho-激酶抑制劑之雙環二氫嘧啶-羧醯胺衍生物
|
|
BR112019015252A2
(pt)
|
2017-01-25 |
2020-04-14 |
Glaxosmithkline Ip Dev Ltd |
compostos
|
|
CN110225910A
(zh)
|
2017-01-25 |
2019-09-10 |
葛兰素史密斯克莱知识产权发展有限公司 |
化合物
|
|
CA3050152A1
(en)
|
2017-01-25 |
2018-08-02 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
WO2018140513A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
CN107176932B
(zh)
|
2017-05-26 |
2020-06-05 |
中国药科大学 |
苯并恶嗪酮衍生物及其制备方法和用途
|
|
WO2019002624A1
(de)
|
2017-06-30 |
2019-01-03 |
Kleuser, Burkhard |
Mittel zur therapie entzündlicher darmerkrankungen
|
|
US11427573B2
(en)
|
2017-08-16 |
2022-08-30 |
Vanderbilt University |
Indazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
|
US11174248B2
(en)
|
2017-10-11 |
2021-11-16 |
Merck Sharp & Dohme Corp. |
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
WO2019074809A1
(en)
|
2017-10-11 |
2019-04-18 |
Merck Sharp & Dohme Corp. |
INDAZOLYL-SPIRO [2.2] PENTANE-CARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
|
|
SG11202003807RA
(en)
|
2017-11-03 |
2020-05-28 |
Univ Montreal |
Compounds and use thereof in the expansion of stem cells and/or progenitor cells
|
|
US20210261553A1
(en)
|
2018-05-15 |
2021-08-26 |
E-Scape Bio, Inc. |
Fused tetrazoles as lrrk2 inhibitors
|
|
WO2020092136A1
(en)
|
2018-10-31 |
2020-05-07 |
Merck Sharp & Dohme Corp. |
N-heteroaryl indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
US20220204473A1
(en)
|
2018-12-25 |
2022-06-30 |
Shanghai Meiyue Biotech Development Co., Ltd. |
Compound as irak inhibitor
|
|
US20220162192A1
(en)
|
2019-03-21 |
2022-05-26 |
ESCAPE Bio, Inc. |
Indazoles as lrrk2 inhibitors
|
|
CN112566905B
(zh)
|
2019-05-10 |
2024-07-30 |
上海海雁医药科技有限公司 |
取代的苯基丙烯基吡啶类衍生物，其制法与医药上的用途
|
|
WO2020247298A2
(en)
|
2019-06-06 |
2020-12-10 |
Merck Sharp & Dohme Corp. |
1-pyrazolyl, 5-, 6- disubstituted indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
WO2021050688A1
(en)
|
2019-09-10 |
2021-03-18 |
X-Chem, Inc. |
Compounds and uses thereof
|
|
CN114072387B
(zh)
|
2019-11-06 |
2024-03-08 |
暨南大学 |
吲唑类化合物及其药用组合物和应用
|
|
CA3181786A1
(en)
|
2020-05-01 |
2021-11-04 |
The Regents Of The University Of California |
Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
|